Cited in | Search | Type: | Patent literature | Publication No.: | US4479938
[DY] (THOMAS WILLIAM R [US]) [DY] 1-5 * claims 1-7 * * example 1 *; | Type: | Patent literature | Publication No.: | EP0346241
[DY] (FOND NAT TRANSFUSION SANGUINE [FR]) [DY] 1-5 * claims 13-15 * * examples 1-3 *; | Type: | Patent literature | Publication No.: | US5344918
[A] (DAZEY BERNARD [FR], et al) [A] 1-17 * claims 1,2 * * column 4, lines 63-68 *; | Type: | Patent literature | Publication No.: | US5891843
[XY] (TURECEK PETER [AT], et al) [XY] 1-5 * abstract;; examples 1-8 * * column 4, lines 32-36 *; | Type: | Patent literature | Publication No.: | US2002115590
[X] (JOHANNESSEN MARIE [DK], et al) [X] 1-5 * claims 1,2 * * paragraphs [0028] , [0052] , [0054] *; | Type: | Non-patent literature | Publication information: | [DX] - TOMOKIYO K ET AL, "Large-scale production and properties of human plasma-derived activated Factor VII concentrate", VOX SANGUINIS, S. KARGER AG, BASEL, CH, (200301), vol. 84, no. 1, ISSN 0042-9007, pages 54 - 64, XP002286502 [DX] 1-5 * abstract * | DOI: | http://dx.doi.org/10.1046/j.1423-0410.2003.00247.x | Type: | Non-patent literature | Publication information: | [X] - HEDNER U ET AL, "CLINICAL EXPERIENCE WITH HUMAN PLASMA-DERIVED FACTOR VIIA IN PATIENTS WITH HEMOPHILIA A AND HIGH TITER INHIBITORS", HAEMOSTASIS, BASEL, CH, (1989), vol. 19, no. 6, pages 335 - 343, XP009058664 [X] 1-5 * abstract * * page 336, column 2, paragraph 2 - page 337, column 1, paragraph 2 * | Type: | Non-patent literature | Publication information: | [A] - BJOERN AND L THIM S ET AL, "Activation of coagulation factor VII to VIIa (S Bjoern and L Thim, Novo Research Institute)", RESEARCH DISCLOSURE, MASON PUBLICATIONS, HAMPSHIRE, GB, (198609), vol. 269, no. 60, ISSN 0374-4353, XP007110994 [A] 1-17 * whole document * |